CENOVUS ENERGY INC - CVECN 3.92 PERP (CVE-PR-B.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:CVE-PR-B • CA15135U4063

24.44 CAD
0 (0%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, CVE-PR-B scores 6 out of 10 in our fundamental rating. CVE-PR-B was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. While CVE-PR-B belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CVE-PR-B has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CVE-PR-B was profitable.
  • CVE-PR-B had a positive operating cash flow in the past year.
  • Of the past 5 years CVE-PR-B 4 years were profitable.
  • Each year in the past 5 years CVE-PR-B had a positive operating cash flow.
CVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 5.83%, CVE-PR-B belongs to the best of the industry, outperforming 87.96% of the companies in the same industry.
  • CVE-PR-B has a Return On Equity of 11.00%. This is amongst the best in the industry. CVE-PR-B outperforms 82.87% of its industry peers.
  • The Return On Invested Capital of CVE-PR-B (7.09%) is better than 86.11% of its industry peers.
  • CVE-PR-B had an Average Return On Invested Capital over the past 3 years of 11.92%. This is significantly above the industry average of 6.50%.
  • The last Return On Invested Capital (7.09%) for CVE-PR-B is well below the 3 year average (11.92%), which needs to be investigated, but indicates that CVE-PR-B had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.83%
ROE 11%
ROIC 7.09%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
CVE-PR-B.CA Yearly ROA, ROE, ROICCVE-PR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • CVE-PR-B's Profit Margin of 6.17% is fine compared to the rest of the industry. CVE-PR-B outperforms 60.65% of its industry peers.
  • In the last couple of years the Profit Margin of CVE-PR-B has declined.
  • Looking at the Operating Margin, with a value of 8.46%, CVE-PR-B is in line with its industry, outperforming 56.94% of the companies in the same industry.
  • CVE-PR-B's Operating Margin has improved in the last couple of years.
  • CVE-PR-B's Gross Margin of 33.16% is in line compared to the rest of the industry. CVE-PR-B outperforms 54.17% of its industry peers.
  • CVE-PR-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.46%
PM (TTM) 6.17%
GM 33.16%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
CVE-PR-B.CA Yearly Profit, Operating, Gross MarginsCVE-PR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • CVE-PR-B has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, CVE-PR-B has less shares outstanding
  • CVE-PR-B has more shares outstanding than it did 5 years ago.
  • CVE-PR-B has a worse debt/assets ratio than last year.
CVE-PR-B.CA Yearly Shares OutstandingCVE-PR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CVE-PR-B.CA Yearly Total Debt VS Total AssetsCVE-PR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • An Altman-Z score of 2.72 indicates that CVE-PR-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CVE-PR-B (2.72) is better than 76.39% of its industry peers.
  • The Debt to FCF ratio of CVE-PR-B is 3.55, which is a good value as it means it would take CVE-PR-B, 3.55 years of fcf income to pay off all of its debts.
  • CVE-PR-B's Debt to FCF ratio of 3.55 is amongst the best of the industry. CVE-PR-B outperforms 83.80% of its industry peers.
  • CVE-PR-B has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • CVE-PR-B has a Debt to Equity ratio of 0.34. This is comparable to the rest of the industry: CVE-PR-B outperforms 59.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.55
Altman-Z 2.72
ROIC/WACC0.96
WACC7.41%
CVE-PR-B.CA Yearly LT Debt VS Equity VS FCFCVE-PR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • A Current Ratio of 1.73 indicates that CVE-PR-B should not have too much problems paying its short term obligations.
  • CVE-PR-B has a better Current ratio (1.73) than 77.31% of its industry peers.
  • CVE-PR-B has a Quick Ratio of 1.18. This is a normal value and indicates that CVE-PR-B is financially healthy and should not expect problems in meeting its short term obligations.
  • CVE-PR-B has a better Quick ratio (1.18) than 70.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.18
CVE-PR-B.CA Yearly Current Assets VS Current LiabilitesCVE-PR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for CVE-PR-B have decreased strongly by -12.76% in the last year.
  • CVE-PR-B shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.97% yearly.
  • The Revenue has decreased by -9.17% in the past year.
  • Measured over the past years, CVE-PR-B shows a very strong growth in Revenue. The Revenue has been growing by 21.88% on average per year.
EPS 1Y (TTM)-12.76%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%71.43%
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-7.4%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.84% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -4.98% on average over the next years.
EPS Next Y30.21%
EPS Next 2Y2.62%
EPS Next 3Y7.13%
EPS Next 5Y22.84%
Revenue Next Year-9.46%
Revenue Next 2Y-8.76%
Revenue Next 3Y-4.98%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CVE-PR-B.CA Yearly Revenue VS EstimatesCVE-PR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
CVE-PR-B.CA Yearly EPS VS EstimatesCVE-PR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • CVE-PR-B is valuated correctly with a Price/Earnings ratio of 14.29.
  • Compared to the rest of the industry, the Price/Earnings ratio of CVE-PR-B indicates a somewhat cheap valuation: CVE-PR-B is cheaper than 70.37% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.93. CVE-PR-B is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 14.15 indicates a correct valuation of CVE-PR-B.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CVE-PR-B indicates a somewhat cheap valuation: CVE-PR-B is cheaper than 67.59% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, CVE-PR-B is valued a bit cheaper.
Industry RankSector Rank
PE 14.29
Fwd PE 14.15
CVE-PR-B.CA Price Earnings VS Forward Price EarningsCVE-PR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CVE-PR-B is valued cheaply inside the industry as 87.96% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CVE-PR-B is valued a bit cheaper than 69.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.36
EV/EBITDA 5.83
CVE-PR-B.CA Per share dataCVE-PR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CVE-PR-B may justify a higher PE ratio.
PEG (NY)0.47
PEG (5Y)0.42
EPS Next 2Y2.62%
EPS Next 3Y7.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.96%, CVE-PR-B has a reasonable but not impressive dividend return.
  • CVE-PR-B's Dividend Yield is a higher than the industry average which is at 3.13.
  • CVE-PR-B's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.96%

5.2 History

  • The dividend of CVE-PR-B is nicely growing with an annual growth rate of 31.72%!
  • CVE-PR-B has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CVE-PR-B has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)31.72%
Div Incr Years3
Div Non Decr Years3
CVE-PR-B.CA Yearly Dividends per shareCVE-PR-B.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • CVE-PR-B pays out 45.02% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CVE-PR-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP45.02%
EPS Next 2Y2.62%
EPS Next 3Y7.13%
CVE-PR-B.CA Yearly Income VS Free CF VS DividendCVE-PR-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
CVE-PR-B.CA Dividend Payout.CVE-PR-B.CA Dividend Payout, showing the Payout Ratio.CVE-PR-B.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CENOVUS ENERGY INC - CVECN 3.92 PERP

TSX:CVE-PR-B (2/6/2026, 7:00:00 PM)

24.44

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)10-31
Earnings (Next)02-12
Inst Owners53.35%
Inst Owner ChangeN/A
Ins Owners0.64%
Ins Owner ChangeN/A
Market Cap46.20B
Revenue(TTM)50.56B
Net Income(TTM)3.12B
Analysts80
Price Target31.55 (29.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.96%
Yearly Dividend0.84
Dividend Growth(5Y)31.72%
DP45.02%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.83%
Min EPS beat(2)40.05%
Max EPS beat(2)177.6%
EPS beat(4)3
Avg EPS beat(4)42.59%
Min EPS beat(4)-72.97%
Max EPS beat(4)177.6%
EPS beat(8)4
Avg EPS beat(8)19.19%
EPS beat(12)7
Avg EPS beat(12)10.58%
EPS beat(16)9
Avg EPS beat(16)-1.72%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-4.97%
Max Revenue beat(2)-4.15%
Revenue beat(4)0
Avg Revenue beat(4)-6.25%
Min Revenue beat(4)-10.43%
Max Revenue beat(4)-4.15%
Revenue beat(8)3
Avg Revenue beat(8)-1.58%
Revenue beat(12)5
Avg Revenue beat(12)-0.2%
Revenue beat(16)9
Avg Revenue beat(16)4.49%
PT rev (1m)1.14%
PT rev (3m)21.26%
EPS NQ rev (1m)0.71%
EPS NQ rev (3m)21.08%
EPS NY rev (1m)15.93%
EPS NY rev (3m)23.64%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)-3.3%
Revenue NY rev (1m)-2.36%
Revenue NY rev (3m)-0.63%
Valuation
Industry RankSector Rank
PE 14.29
Fwd PE 14.15
P/S 0.91
P/FCF 16.36
P/OCF 5.89
P/B 1.63
P/tB 1.82
EV/EBITDA 5.83
EPS(TTM)1.71
EY7%
EPS(NY)1.73
Fwd EY7.07%
FCF(TTM)1.49
FCFY6.11%
OCF(TTM)4.15
OCFY16.99%
SpS26.75
BVpS15.01
TBVpS13.46
PEG (NY)0.47
PEG (5Y)0.42
Graham Number24.03
Profitability
Industry RankSector Rank
ROA 5.83%
ROE 11%
ROCE 8.93%
ROIC 7.09%
ROICexc 7.38%
ROICexgc 7.88%
OM 8.46%
PM (TTM) 6.17%
GM 33.16%
FCFM 5.59%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
ROICexc(3y)12.89%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)15.07%
ROCE(5y)N/A
ROICexgc growth 3Y-0.51%
ROICexgc growth 5Y16.37%
ROICexc growth 3Y0.11%
ROICexc growth 5Y16.58%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
F-Score5
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.55
Debt/EBITDA 1.04
Cap/Depr 99.6%
Cap/Sales 9.94%
Interest Coverage 250
Cash Conversion 84.18%
Profit Quality 90.48%
Current Ratio 1.73
Quick Ratio 1.18
Altman-Z 2.72
F-Score5
WACC7.41%
ROIC/WACC0.96
Cap/Depr(3y)91.58%
Cap/Depr(5y)68.62%
Cap/Sales(3y)7.67%
Cap/Sales(5y)7.01%
Profit Quality(3y)110.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.76%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%71.43%
EPS Next Y30.21%
EPS Next 2Y2.62%
EPS Next 3Y7.13%
EPS Next 5Y22.84%
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-7.4%
Revenue Next Year-9.46%
Revenue Next 2Y-8.76%
Revenue Next 3Y-4.98%
Revenue Next 5YN/A
EBIT growth 1Y-20.33%
EBIT growth 3Y1.79%
EBIT growth 5Y24.73%
EBIT Next Year102.61%
EBIT Next 3Y32.13%
EBIT Next 5Y21.11%
FCF growth 1Y-6.18%
FCF growth 3Y7.94%
FCF growth 5Y14.96%
OCF growth 1Y5.9%
OCF growth 3Y15.98%
OCF growth 5Y22.96%

CENOVUS ENERGY INC - CVECN 3.92 PERP / CVE-PR-B.CA FAQ

Can you provide the ChartMill fundamental rating for CENOVUS ENERGY INC - CVECN 3.92 PERP?

ChartMill assigns a fundamental rating of 6 / 10 to CVE-PR-B.CA.


Can you provide the valuation status for CENOVUS ENERGY INC - CVECN 3.92 PERP?

ChartMill assigns a valuation rating of 6 / 10 to CENOVUS ENERGY INC - CVECN 3.92 PERP (CVE-PR-B.CA). This can be considered as Fairly Valued.


How profitable is CENOVUS ENERGY INC - CVECN 3.92 PERP (CVE-PR-B.CA) stock?

CENOVUS ENERGY INC - CVECN 3.92 PERP (CVE-PR-B.CA) has a profitability rating of 7 / 10.


Can you provide the financial health for CVE-PR-B stock?

The financial health rating of CENOVUS ENERGY INC - CVECN 3.92 PERP (CVE-PR-B.CA) is 6 / 10.


What is the expected EPS growth for CENOVUS ENERGY INC - CVECN 3.92 PERP (CVE-PR-B.CA) stock?

The Earnings per Share (EPS) of CENOVUS ENERGY INC - CVECN 3.92 PERP (CVE-PR-B.CA) is expected to grow by 30.21% in the next year.